These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8441174)

  • 1. Plasminogen activators and plasminogen activator inhibitors in synovial fluid. Difference between inflammatory joint disorders and osteoarthritis.
    Saxne T; Lecander I; Geborek P
    J Rheumatol; 1993 Jan; 20(1):91-6. PubMed ID: 8441174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Difference in expression of the plasminogen activation system in synovial tissue of patients with rheumatoid arthritis and osteoarthritis.
    Ronday HK; Smits HH; Van Muijen GN; Pruszczynski MS; Dolhain RJ; Van Langelaan EJ; Breedveld FC; Verheijen JH
    Br J Rheumatol; 1996 May; 35(5):416-23. PubMed ID: 8646430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tiaprofenic acid on plasminogen activators and inhibitors in human OA and RA synovium.
    Pelletier JP; McCollum R; Cloutier JM; Martel-Pelletier J
    Br J Rheumatol; 1992; 31 Suppl 1():19-26. PubMed ID: 1555050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activators and their inhibitors in synovial fluids from normal, osteoarthritis, and rheumatoid arthritis knees.
    Belcher C; Fawthrop F; Bunning R; Doherty M
    Ann Rheum Dis; 1996 Apr; 55(4):230-6. PubMed ID: 8733439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depression of tissue-type plasminogen activator and enhancement of urokinase-type plasminogen activator as an expression of local inflammation.
    Brommer EJ; Dooijewaard G; Dijkmans BA; Breedveld FC
    Thromb Haemost; 1992 Aug; 68(2):180-4. PubMed ID: 1412164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevations in synovial fluid plasminogen activator in patients with rheumatoid arthritis.
    Mochan E; Uhl J
    J Rheumatol; 1984 Apr; 11(2):123-8. PubMed ID: 6427461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of intraarticular fibrinolytic pathways in patients with inflammatory and noninflammatory joint diseases.
    Kummer JA; Abbink JJ; de Boer JP; Roem D; Nieuwenhuys EJ; Kamp AM; Swaak TJ; Hack CE
    Arthritis Rheum; 1992 Aug; 35(8):884-93. PubMed ID: 1379429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen activators in synovial fluid and plasma from patients with arthritis.
    Brommer EJ; Dooijewaard G; Dijkmans BA; Breedveld FC
    Ann Rheum Dis; 1992 Aug; 51(8):965-8. PubMed ID: 1417121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of the chondrocyte fibrinolytic balance by the drug piroxicam: relevance to the osteoarthritic process.
    Fibbi G; Serni U; Matucci A; Mannoni A; Pucci M; Anichini E; Del Rosso M
    J Rheumatol; 1994 Dec; 21(12):2322-8. PubMed ID: 7699636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mobilization of fibrinolytic enzymes in synovial fluid and plasma of rheumatoid arthritis and spondyloarthropathy and their relation to radiological destruction.
    Wållberg-Jonsson S; Rantapää-Dahlqvist S; Nordmark L; Rånby M
    J Rheumatol; 1996 Oct; 23(10):1704-9. PubMed ID: 8895144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
    Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
    J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator in synovial fluid from patients with rheumatoid arthritis.
    Kikuchi H; Tanaka S; Matsuo O
    J Rheumatol; 1987 Jun; 14(3):439-45. PubMed ID: 3625626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Levels of matrix metalloproteinase-3 and urokinase-type plasminogen activator in knee synovial fluids from patients with rheumatoid arthritis and osteoarthritis].
    Gotoh H; Yamada H; Yoshihara Y; Kikuchi T; Obata K; Shinmei M
    Ryumachi; 1997 Feb; 37(1):3-8. PubMed ID: 9128417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of plasminogen activator activity in arthritic joints.
    Hamilton JA; Hart PH; Leizer T; Vitti GF; Campbell IK
    J Rheumatol Suppl; 1991 Feb; 27():106-9. PubMed ID: 1902874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmin, plasminogen activators and inhibitor in human osteoarthritic cartilage.
    Martel-Pelletier J; Faure MP; McCollum R; Mineau F; Cloutier JM; Pelletier JP
    J Rheumatol; 1991 Dec; 18(12):1863-71. PubMed ID: 1724464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of urinary trypsin inhibitor on osteoarthritis.
    Matsuo O; Tanaka S; Kikuchi H
    Thromb Res; 1988 Nov; 52(3):237-45. PubMed ID: 3143165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1 beta, plasminogen activator and inhibitor of plasminogen activator in synovial fluid of rheumatoid arthritis, psoriatic arthritis and osteoarthritis.
    Pianon M; Punzi L; Stefani MP; Bertazzolo N; Michelotto M; Finco B; Gambari PF
    Agents Actions; 1994 Mar; 41(1-2):88-9. PubMed ID: 8079828
    [No Abstract]   [Full Text] [Related]  

  • 18. Determination of metalloproteinases, plasminogen-activators and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesis.
    Blaser J; Triebel S; Maasjosthusmann U; Romisch J; Krahl-Mateblowski U; Freudenberg W; Fricke R; Tschesche H
    Clin Chim Acta; 1996 Jan; 244(1):17-33. PubMed ID: 8919199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen activator inhibitors type 1 and type 2 and plasminogen activators in amniotic fluid during pregnancy.
    Estellés A; Gilabert J; Andrés C; España F; Aznar J
    Thromb Haemost; 1990 Oct; 64(2):281-5. PubMed ID: 2125378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
    J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.